How much is KaloCyte worth in 2026?

KaloCyte has a current valuation of N/A based on their Later Stage VC round and secondary market data.

How much funding has KaloCyte raised?

KaloCyte has raised $5.7M in total funding across 1 funding rounds.

KaloCyte

BiotechnologyWebsite

KaloCyte valuation and funding history | Last updated: January 1, 2020 | 1 funding rounds

Current Valuation

N/A

As of January 1, 2020

Total Funding Raised

$5.7M

Across 1 round

Last Round

Later Stage VC

$15.0M

Last Funding

Jan 2020

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
January 1, 2020	Accelerator/Incubator	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

KaloCyte is currently valued at N/A as of January 1, 2020. The company has raised a total of $5.7M in funding across 1 funding round.

Track KaloCyte Valuation Updates

Get notified when KaloCyte raises new funding or valuation changes

Explore More Data

Detailed analysis for KaloCyte

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock KaloCyte's valuation history, funding rounds, and growth metrics.

No credit card required

What is KaloCyte Worth in 2026?

KaloCyte is a leading private company in the Biotechnology sector. Track KaloCyte's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How KaloCyte Valuation is Determined

Private company valuations like KaloCyte's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.